TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Quantitation of Aggrecatibacter actinomycetemcomitans and Porphyromonas gingivalis bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Precision of Vision-700 in Retinal and Cornea Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Precision of 3D OCT-1 in Retinal and Cornea Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement of Vision-700 and 3D OCT-1 in Retinal and Cornea Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post operative sore throat
Endpoint domain: Adverse events/effects
Primary endpoint: Performance of VisioCyt® test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: surgeon satisfaction with remifentanil-dexmedetomidine sedation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: surgeon satisfaction with dexmedetomidine-fentanyl sedation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: patient satisfaction with remifentanil-dexmedetomidine sedation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: patient satisfaction with dexmedetomidine-fentanyl sedation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in using a reliable method(s) of birth control
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in abstinence
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Recurrent fistula in ano
Endpoint domain: Adverse events/effects
Primary endpoint: Recurrent perianal abscess
Endpoint domain: Adverse events/effects
Primary endpoint: Total score of health-reported quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Achievement of complete cervical dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Determination of DLTs
Endpoint domain: Adverse events/effects
Primary endpoint: Skin Cancer Sun Knowledge Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of parents who apply SSE to their children
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Parental sun protection scale rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency, duration and severity of Solicited Symptoms of Reactogenicity
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency, duration, and severity of unsolicited adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency, duration, and severity of serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency, duration, and severity of adverse events of special interest (AESIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency, duration, and severity of New Onset of Chronic Illness (NOCIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Remember/Familiar Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Confidence Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Vividness Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Time required for defecation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Adverse effect after using facial cleanser X
Endpoint domain: Adverse events/effects
Primary endpoint: Muscle protein fractional synthetic rate (postabsorptive)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Muscle protein fractional synthetic rate (postprandial)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diagnostic yield for the detection of granulomas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weight gain over the 8 week intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Complete or Partial Overall Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients recommended not to do
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mini-Mental State Examination scale score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: The Functional Movement Scale (FMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain volumetric measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain connectivity measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delta of PaO2: FiO2 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Crohn's disease mucosal healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ulcerative Colitis Mucosal healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory Rate accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Dermatitis severity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Injections number
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Injections interval
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patterns of relapse after Neoadjuvant Chemotherapy
Endpoint domain: Mortality/survival
Primary endpoint: Serum level of platelet factor 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of women not delivered within 48 hours of starting tocolytic therapy
Endpoint domain: Mortality/survival
Primary endpoint: Time to first rescue analgesia post-operative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive function related to delirium
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Severity of postoperative delirium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Intraoperative respiratory system mechanics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Depression Scores (Hamilton Depression Rating)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Depression Scores (Montgomery-Åsberg Depression Rating Scale)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Depression Scores (Beck Depression Inventory)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Anxiety Scores (Beck Anxiety Inventory)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Smartphone addiction scale (SAS)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in umbilical artery dopplers systolic/diastolic ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Patients with Dose Limiting Toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of integrating TT into primary healthcare
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability of integrating TT into primary healthcare
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Appropriateness of integrating TT into primary healthcare
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Area under the plasma concentration-time curve from 0 to tlast (AUC0-tlas) of omaveloxolone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve from 0 extrapolated to infinity (AUC0-∞) of omaveloxolone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of all AEs /SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Epitrack scale score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: uptake of [11C]-CS1P1 tracer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: VNS biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Currently Using PPFP
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in degenerative joint disease symptoms in coxarthrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in degenerative joint disease symptoms in rhizoarthrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Behavioral pain scale
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Necessity and duration of non-invasive/invasive ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: hemodynamic variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-hour hyperglycemic clamp
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Composite measures of suicide attempt and death
Endpoint domain: Mortality/survival
Primary endpoint: changes in Montreal Cognitive Assessment (MoCA)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: 24-hour opioid consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants with confirmed smoking abstinence at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with confirmed smoking abstinence at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with confirmed smoking abstinence at 24 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived stress assessment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: elevated mitochondrial DNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Outpatient Hospitalization Rate
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Cumulative postoperative opioid use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Presence of dental caries after the intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain after wisdom tooth extraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Edema after wisdom tooth extraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trismus after wisdom tooth extraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of tolerance to cow milk products
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of sphincter disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Typology of sphincter disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of Major Depressive Disorder (MDD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee Position Sense
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of Pain, Function, and Stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain assessment using DN4 Pain Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comfort assessment using General Comfort Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Peripheral skin temperature measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants that had a vaccine produced for them
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Metabolic Syndrome Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of inseminated oocytes developed to optimal blastocysts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Occurrence of symptomatic cystitis-like episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of serious treatment-emergent adverse events (TESAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of TEAEs leading to interruption or early termination of study treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Mental Health Literacy (MHL)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post-partum bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Reduction of weekly cluster headache attack frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to attach the PPF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of planned mastoidectomy reachable by robot
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cardiac Rehabilitation Participation
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Cardiac Rehabilitation Adherence
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: VascuQoL-6 Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Clotting times of whole blood samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: European Heart Failure Self-Care Behavior Scale for Caregivers
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Scale of Caregiver Contribution in Heart Failure Self-Care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Internal jugular venous saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subject retention at initial follow-up assessment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Donor and recipient site assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Qualitative assessment of the intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pinch Gauge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of first pass effect (FPE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Erectile Function domain score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in ERN after intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in balance N1 after intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric Mean Titer (GMT) of Anti-Hemagglutinin (HA) Antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants With Solicited Local and Systemic Reactogenicity Adverse Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Participants Likely to Vaccinate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subdural Hematoma recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Depth of sedation indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fat and thin tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adipocytokine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Inflammatory factor index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Blood fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of patients with a platelet count ≥75×10^9/L and an increase of platelet count more than 20% from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Comparison of total amount of postoperative drainage fluid between treatment group and control group
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of Post-Operative Pancreatic Fistula
Endpoint domain: Adverse events/effects
Primary endpoint: Hard tissue change (bone profil retraction)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Soft tissue change (gingival retraction)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage of participants who remain on their 'index systemic' therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of Participants Ceasing Their 'Index Systemic' Therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to Cessation of Index Systemic Therapy From Baseline
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: CVSS17 Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Therapeutic Alliance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Treatment Adherence
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: PrEP adherence at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Proportion of Participants with SRQ-20 Scores Below 7
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cumulative incidence of grade III-IV GvHD
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of adverse events related to SMART101
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Visual Field mean deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of phosphorylated STAT5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in microbial community structure/composition/function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Assessment Cosmesis at 3 years
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Expression of PCSK9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulating tumor deoxyribonucleic acid (ctDNA) clearance rate
Endpoint domain: Mortality/survival
Primary endpoint: tDNA recurrence-free survival rate (ctDNA-RFS)
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery rate from SAM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Competency level of nurses
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Crohn's Disease Activity Index score (CDAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central voluntary activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Six minutes walking test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of alarm fatigue
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in biofilm index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Outcome Questionnaire (OQ-45)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Patient opinion regarding the use of artificial intelligence in radiology
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-reported sensation/discomfort during kTMP stimulation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-reported sensation/discomfort after kTMP stimulation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Motor evoked potential (MEPs) amplitude before kTMP stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor evoked potential (MEPs) amplitude after kTMP stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Child maltreatment - physical and emotional abuse (Parent Report)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Child maltreatment - physical and emotional abuse (Child Report on Male Parent Figure)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Child maltreatment - physical and emotional abuse (Child Report on Female Parent Figure)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Intimate partner violence - perpetration (Parent-report)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Intimate partner violence - victimisation (Parent-report)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Partner conflict (Child Report)
Endpoint domain: Adverse events/effects
Primary endpoint: Safety measure after first infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Kidney Disease and Quality of Life (KDQOL-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life